Lost Money in Hub Group (NASDAQ: HUBG)? Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Lost Money in Hub Group (NASDAQ: HUBG)? Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.–(BUSINESS WIRE)–
Shares of Hub Group, Inc. have dropped by over 22% since the company announced on February 5, 2026, that it had discovered an accounting error, rendering its prior financial statements likely inaccurate, and would delay the release of its Q4 and full-year financial results. Gibbs Mura continues to investigate a potential Hub Group, Inc. (NASDAQ: HUBG) Securities Class Action Lawsuit concerning whether Hub Group has violated federal securities laws by providing false or misleading statements to investors.

YOU MAY BE ABLE TO RECOVER YOUR LOSSES. VISIT OUR HUB GROUP CLASS ACTION LAWSUIT INVESTIGATION WEBPAGE OR CALL US AT (888) 410-2925 TO LEARN MORE.

What is the Hub Group Investigation About?

On February 5, 2026, Hub Group revealed an accounting error that resulted in a $77 million understatement of “purchased transportation costs and accounts payable during the first three quarters of 2025.” Hub Group now estimates that correcting the error will increase purchased transportation and warehousing costs for the first three quarters of 2025, “but cannot yet estimate what the resulting increase to purchased transportation and warehousing costs and accounts payable will be,” the company said in a news release.

Hub Group also said it plans to restate its financial statements for the first three quarters of 2025 and continue “to assess the potential impact to its consolidated financial statements for the years ended December 31, 2024 and 2023.”

About Gibbs Mura, A Law Group

Gibbs Mura represents investors nationwide in securities litigation. The firm has recovered billions of dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

PRESS CONTACT: CATHERINE CONROY

PHONE: 510.350.9705

EMAIL: [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

Evommune Announces $125 Million Private Placement

Evommune Announces $125 Million Private Placement

PALO ALTO, Calif. & NEW YORK–(BUSINESS WIRE)–
Evommune, Inc. (“Evommune” or the “Company”) (NYSE: EVMN), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that it has entered into a securities purchase agreement to sell 4,494,279 shares of its common stock to a select group of new and existing mutual funds and dedicated healthcare institutional investors in a private placement. The purchase price of each share of common stock is $27.88. Evommune anticipates the gross proceeds from the private placement to be approximately $125 million, before deducting any transaction-related expenses. The private placement is expected to close on or about February 17, 2026, subject to the satisfaction of customary closing conditions.

Morgan Stanley & Co. LLC, Leerink Partners LLC, Evercore ISI, Cantor Fitzgerald & Co., and William Blair & Company, L.L.C. acted as placement agents for the private placement. Oppenheimer & Co. Inc. acted as capital markets advisor for the private placement.

Evommune intends to use the net proceeds from the private placement to advance its clinical development programs and for general corporate purposes.

The offer and sale of the securities to be sold in the private placement have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other applicable jurisdiction’s securities laws, and such securities may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdiction’s securities laws. Concurrently with entering into the securities purchase agreement, Evommune and the investors entered into a registration rights agreement pursuant to which Evommune has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares of common stock issued in the private placement.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

About Evommune, Inc.

Evommune, Inc. is a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases. The Company’s mission is to improve patients’ daily lives and prevent the long-term effects of uncontrolled inflammation that are a consequence of the limitations of existing therapies. To achieve this, Evommune is advancing a portfolio of differentiated product candidates that target key drivers of chronic inflammation.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements in this press release other than statements of historical facts are “forward-looking statements.” These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will” and variations of these words or similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements in this press release include, but are not limited to, statements concerning expected proceeds from the private placement, expected use of proceeds, and expected closing of the private placement. These forward-looking statements are based on the Company’s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties that could cause the Company’s clinical development programs, future results or performance to differ materially from those expressed or implied by the forward-looking statements. Many factors may cause differences between current expectations and actual results, including: the Company’s limited operating history and historical losses; the potential that success in preclinical testing and earlier clinical trials does not ensure that later clinical trials will generate the same results or otherwise provide adequate data to demonstrate the efficacy and safety of a product candidate; the Company’s ability to obtain regulatory approval of and successfully commercialize its product candidates; the impacts of macroeconomic conditions, including heightened inflation and uncertain credit and financial markets, on the Company’s business, clinical trials and financial position; unexpected safety or efficacy data observed during preclinical studies or clinical trials; clinical trial site activation or enrollment rates that are lower than expected; the Company’s ability to realize the benefits of its collaborations and license agreements; changes in expected or existing competition; changes in the regulatory environment; the Company’s ability to obtain, maintain and protect its intellectual property; and unexpected litigation or other disputes. Other factors that may cause the Company’s actual results to differ from those expressed or implied in the forward-looking statements in this press release are identified under the heading “Risk Factors” in the Company’s Quarterly Report on Form 10-Q, filed with the SEC on December 11, 2025, and in other filings that the Company makes and will make with the SEC in the future. The Company expressly disclaims any obligation to update any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law.

Media:

Paul Laland

[email protected]

Investors:

Sarah McCabe

[email protected]

KEYWORDS: United States North America California New York

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Logo
Logo

Therma-Tru to Unveil ¾-Lite Shaker Doors and Sidelites at International Builders’ Show

Therma-Tru to Unveil ¾-Lite Shaker Doors and Sidelites at International Builders’ Show

DEERFIELD, Ill.–(BUSINESS WIRE)–
Therma-Tru, the leader in complete entry and patio door system innovation, will introduce its new ¾-lite flush-glazed Shaker-style doors and sidelites at the 2026 International Builders’ Show (IBS), Booth #W3267, Feb. 17–19 in Orlando.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212325085/en/

Therma-Tru to Unveil ¾-Lite Shaker Doors and Sidelites at International Builders’ Show

Therma-Tru to Unveil ¾-Lite Shaker Doors and Sidelites at International Builders’ Show

“Shaker style continues to resonate because it’s simple, versatile and timeless,” said Eric Dotson, vice president, product management for outdoors B2B at Fortune Brands. “Our new ¾-lite Shaker doors and sidelites give builders and homeowners more design flexibility at the front entry, balancing natural light, curb appeal and the proven performance they expect from Therma-Tru door systems.”

Expanding on the success of the Shaker portfolio, the new ¾-lite design captures the clean lines homeowners favor, while allowing in more sunlight. Available in Therma-Tru Fiber-Classic and Smooth-Star 1-panel doors, its balanced profile and versatile styling complement a variety of architectural and decorative elements, including Craftsman, Coastal and other popular design influences. Privacy and textured, energy-efficient Low-E glass, along with divided lite styles, round out the selection.

Doors and sidelites come in 6’8″ and 8′ sizes and feature composite top and bottom rails and edge stiles with Tru-Guard composite technology, providing advanced protection from water absorption, mold and wood-ingesting insects on all six sides of the door. Backed by a lifetime limited warranty, its durable, long-lasting fiberglass skins won’t warp, rot, dent or rust, and require very little maintenance.

Therma-Tru will also showcase the complete door system line-up at IBS, including its Veris Entryway Systems, which offer extensive customization options across operation, size, configuration, style and privacy. Veris brings together high-end style and unique functionality to create contemporary openings that become experiences. Engineered for easy, worry-free operation and designed with the highest quality aluminum, stainless steel and polymer components which provide long-lasting operation that’s virtually maintenance-free.

Booth #W3267 will also display Therma-Tru sister brands Larson (storm doors), Fiberon (decking, railing and cladding), Fypon (decorative millwork) and Solar Innovations (custom glass doors, windows and structures), featuring a legacy of more than 200 combined years of material science expertise and product innovation. No other brand portfolio offers as diverse a range of products for the outer home. Showcasing the brands together allows customers to experience the collective of these brands as they were intended — to inspire them to manifest their outer home.

Proven to perform, protect and preserve, a Therma-Tru complete door system is the culmination of more than 60 years of expertise in material science, engineering and manufacturing. Its on-trend doors are tested against extreme environmental conditions — far beyond industry standards — to ensure maximum durability and safety.

About Therma-Tru

Therma-Tru is the leading entry door brand most preferred by building professionals. Founded in 1962, Therma-Tru pioneered the fiberglass entry door industry, and today offers a complete portfolio of entry door system solutions proven to outlast and outperform wood and steel. Therma-Tru is part of Fortune Brands Innovations, Inc. (NYSE: FBIN). Learn more at www.thermatru.com.

About Fortune Brands Innovations

Fortune Brands Innovations, Inc. (NYSE: FBIN), headquartered in Deerfield, Ill., is a brand, innovation and channel leader focused on exciting, supercharged categories in the home products, security and commercial building markets. The Company’s growing portfolio of brands includes Moen, House of Rohl, Aqualisa, Emtek, Therma-Tru, Larson, Fiberon, Master Lock, SentrySafe, Yale residential and August. To learn more about FBIN, its brands and environmental, social and governance (ESG) commitments, visit www.FBIN.com.

Amy Evans

317-873-8100 x281

[email protected]

KEYWORDS: Florida Illinois United States North America

INDUSTRY KEYWORDS: Retail Architecture Chemicals/Plastics Manufacturing Other Construction & Property Home Goods Residential Building & Real Estate Commercial Building & Real Estate Construction & Property Building Systems Other Retail Specialty Other Manufacturing Interior Design

MEDIA:

Photo
Photo
Therma-Tru to Unveil ¾-Lite Shaker Doors and Sidelites at International Builders’ Show
Logo
Logo

Namib Minerals Commences Dewatering at Redwing Mine in Support of Restart Project

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), today provided an update on progress at its Redwing Mine in Zimbabwe, confirming that dewatering activities commenced on January 29, 2026, in line with the work plan outlined in the Company’s November 2025 business update. The dewatering phase will enable access to the mine for feasibility studies, including underground condition assessments and detailed engineering evaluations, which will inform the next stages of the restart project at Redwing.

The Company noted that progress to date is consistent with the planned enabling works and reflects the Company’s disciplined, safety-focused approach to restarting production at the Redwing Mine.

“Dewatering at Redwing is progressing as planned and represents an important milestone in the restart process,” said Ibrahima Tall, Chief Executive Officer of Namib Minerals. “We are focused on building Namib Minerals into a mid-tier gold producer, targeting meaningful reserve growth, with Redwing’s future restart representing an important step toward that goal.”

#             #             #

About Namib Minerals

Namib Minerals (NASDAQ: NAMM) is a gold producer, developer and explorer with operations focused in Zimbabwe. Namib Minerals is a significant player in Africa’s mining industry, driving sustainable growth and innovation across the sector. Currently Namib Minerals operates the How Mine, an underground gold mine in Zimbabwe, and aims to restart two assets in Zimbabwe. For additional information, please visit namibminerals.com.

Forward-
Looking
Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts contained in this update are forward-looking statements. Any statements that refer to estimates or other characterizations of future events or circumstances, including any underlying assumptions, are also forward-looking statements. Forward-looking statements include, without limitation, the prospects of the restart project at the Redwing Mine including related feasibility studies. The forward-looking statements are based on our current expectations and are inherently subject to uncertainties and changes in circumstance and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks and uncertainties which include the Company’s ability to execute on its plans and raise required capital for the restart. The foregoing list is not exhaustive. You should carefully consider the foregoing factors, any other factors discussed in this press release and the other risks and uncertainties described in the filings we make with Securities and Exchange Commission. We caution you against placing undue reliance on forward-looking statements, which reflect current beliefs and are based on information currently available as of the date a forward-looking statement is made.

Contacts:

Investor Relations:
[email protected]



MPT Declares Regular Quarterly Dividend

MPT Declares Regular Quarterly Dividend

BIRMINGHAM, Ala.–(BUSINESS WIRE)–
MPT (the “Company” or “MPT”) (NYSE: MPT) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on April 9, 2026, to stockholders of record on March 12, 2026.

Annual Meeting of Stockholders

Medical Properties Trust also announced that its annual meeting of stockholders will be at UAB Collat School of Business at 10:30 a.m. Central Time on May 28, 2026, in Birmingham, Alabama. Stockholders of record as of March 19, 2026, will be invited to attend.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 388 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of September 30, 2025. MPT’s financing model facilitates acquisitions and recapitalizations, and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at MPT.com.

Charles Lambert

Senior Vice President of Finance & Treasurer

Medical Properties Trust, Inc.

(205) 397-8897

[email protected]

KEYWORDS: Alabama United States North America

INDUSTRY KEYWORDS: Health Other Construction & Property Hospitals Commercial Building & Real Estate Construction & Property Building Systems REIT

MEDIA:

Logo
Logo

Aura FAT Projects Acquisition Corp Signs Binding Letter of Intent with Dalmore for Proposed Business Combination

BRISBANE, Australia, Feb. 12, 2026 (GLOBE NEWSWIRE) — Aura FAT Projects Acquisition Corp (“AFAR”), a special purpose acquisition company, and Dalmore Holdings Pty Ltd (“Dalmore”) have entered into a binding Letter of Intent (“LOI”) in connection with a proposed business combination. Upon completion, the combined company is expected to be publicly listed on a national securities exchange in the United States.

Under the terms of the LOI, all existing Dalmore shareholders are to roll their equity into the combined company.

In connection with the proposed transaction, AFAR expects to raise additional capital through a private investment in public equity (“PIPE”) financing to support the combined company’s growth objectives and future development plans.

The LOI is subject to completion of due diligence and final transaction structuring, and includes customary exclusivity, confidentiality, and other provisions. No assurances can be provided as to the entry into or timing of any definitive agreement or the consummation of any transaction. Completion of the transaction remains subject to the completion of satisfactory due diligence, negotiation of definitive agreements, shareholder and regulatory approvals, and other customary closing conditions. The parties will announce additional details regarding the proposed business combination if and when a definitive agreement is executed.

Operational Progress at Dalmore

Dalmore owns and operates the Wilkie Creek open-cut coal mine in Queensland’s Surat Basin, a historic Australian coal asset with an anticipated legacy production run rate of approximately 2.6 million tonnes per annum, and a planned ramp-up to approximately 3.7 million tonnes per annum.

Following a comprehensive operational and financial restructuring, Dalmore is working towards executing its first shipments of high-quality Australian coal, marking a key milestone in the recommencement of commercial operations. These initial shipments have been enabled by development and working capital funding provided by Blackbird Capital, a privately held financial services company based in Australia, which has supported the recommissioning of the mine, logistics readiness, and early customer deliveries.

The recommencement of Wilkie Creek’s commercial operations is expected to deliver renewed economic activity in the Dalby region of Queensland, including job creation, increased demand for local services, and broader regional supply-chain engagement.

Advisors

Hall Chadwick is serving as Corporate Advisor to Dalmore. Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC is serving as exclusive financial advisor and lead capital markets advisor to AFAR. The Loev Law Firm, PC is serving as legal counsel to AFAR. Duane Morris LLP is serving as legal counsel to Dalmore.

Additional Information and Where to Find It

If a definitive agreement is entered into in connection with the proposed business combination, AFAR or a newly formed holding company will prepare and file a registration statement on Form S-4, including a preliminary proxy statement/prospectus (the “Proxy Statement”) with the U.S. Securities and Exchange Commission (the “SEC”). AFAR urges investors and securityholders to read the Proxy Statement and other documents filed with the SEC when they become available, as they will contain important information regarding the proposed business combination. The Proxy Statement will be distributed to holders of AFAR’s shares in connection with AFAR’s solicitation of proxies for the vote by AFAR’s shareholders with respect to the proposed business combination and other matters as will be described therein. All SEC filings will be available free of charge at www.sec.gov, or by directing a request to: Aura FAT Projects Acquisition Corp, 1 Phillip Street, #09-00, Royal One Phillip, Singapore, 048692, Attention: David Andrada, or by email at [email protected].

Participants in the Solicitation

AFAR, Dalmore, and their respective directors, officers, and employees may be deemed participants under SEC rules in the solicitation of proxies in connection with the proposed business combination. Information about AFAR’s directors and officers is available in AFAR’s SEC filings. Additional details regarding the interests of persons involved in the proposed business combination will be included in the proxy statement/prospectus when it becomes available.

Forward-Looking Statements

All information in this press release concerning Dalmore has been provided solely by Dalmore and has not been independently verified by AFAR, which makes no representation or warranty regarding the accuracy or completeness of such information and assumes no obligation to update the information in this press release, except as required by law. This press release includes “forward-looking statements” with respect to AFAR and Dalmore. The expectations, estimates, and projections of the businesses of Dalmore and AFAR may differ from their actual results, and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, expectations with respect to the execution and delivery of a definitive agreement with respect to the proposed business combination, future performance and anticipated financial impacts of the proposed business combination, the satisfaction of the closing conditions to the proposed business combination, and the timing of the completion of the proposed business combination. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside of the control of AFAR and Dalmore and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the negotiations and any subsequent definitive agreements with respect to the proposed business combination, and the possibility that the terms and conditions set forth in any definitive agreements with respect to the proposed business combination may differ materially from the terms and conditions set forth in the letter of intent; (2) the outcome of any legal proceedings that may be instituted against the parties following the announcement of the proposed business combination and any definitive agreements with respect thereto; (3) the inability to complete the proposed business combination, including due to failure to obtain approval of the shareholders of AFAR and Dalmore or other conditions to closing; (4) the inability to obtain or maintain the listing of the combined company’s securities on the Nasdaq Stock Market LLC, the New York Stock Exchange, or another national securities exchange following the proposed business combination; (5) the risk that the proposed business combination disrupts current plans and operations as a result of the announcement and consummation of the proposed business combination; (6) the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably and retain its key employees; (7) costs related to the proposed business combination; (8) changes in applicable laws or regulations; (9) risks related to Dalmore’s business, including fluctuations in demand and prices for coal and other commodities, competition within the industry, the risks inherent in mining operations, development projects and exploration activities, potential delays or cost overruns in capital expenditures, the ability to secure necessary raw materials and offtake arrangements, compliance with regulatory requirements, environmental and safety obligations, economic and market conditions, and political or geopolitical developments; (10) the “Risk Factors” sections of the most recent Annual Report on Form 10-K filed with the SEC by AFAR; and (11) other risks and uncertainties included in documents filed or to be filed with the SEC by AFAR, Dalmore and the combined company.

The foregoing list of factors is not exclusive. You should not place undue reliance upon any forward-looking statements, which speak only as of the date made. AFAR and Dalmore do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions, or circumstances upon which any such statement is based, except as required by law. Past performance by AFAR and Dalmore is not a guarantee of future performance. Therefore, you should not place undue reliance on the historical record of the performance of AFAR and Dalmore as indicative of future performance of an investment or the returns that AFAR and Dalmore will, or are likely to, generate going forward.

No Offer or Solicitation

This press release shall not constitute a solicitation of a proxy, consent, or authorization with respect to any securities or regarding the proposed business combination. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction where such offer, solicitation, or sale would be unlawful under the securities laws of any such jurisdiction.

About Aura FAT Projects Acquisitions Corp

Aura FAT Projects Acquisitions Corp is a special purpose acquisition company led by an experienced management team and board of directors with a track record of sourcing and executing business combination transactions. AFAR’s business strategy is to identify companies that its management and board believes have compelling potential for value creation.  

About Dalmore Holdings Pty Ltd

As described more fully above, Dalmore Holdings Pty Ltd is an Australian private mining company focused on the revitalization of the Wilkie Creek open-cut coal mine in Queensland, Australia. 

Media Contact
Mike Willesee
[email protected] 



IREN Added to MSCI USA Index

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN”) today announced it will be added to the MSCI USA Index, effective after close of trading on February 27, 2026.

The MSCI USA Index measures the performance of large and mid cap segments of the U.S. equity market and represents approximately 85% of the free float-adjusted market capitalization in the US.

This inclusion is expected to enhance IREN’s visibility among institutional investors and index-tracking funds.

Daniel Roberts, Co-Founder and Co-CEO of IREN, commented: “Being added to the MSCI USA Index reflects the scale and liquidity we have built in the business. We believe this milestone will broaden institutional access to IREN as we continue to execute on our AI Cloud strategy.”

About IREN

IREN is a leading AI Cloud Service Provider, delivering large-scale GPU clusters for AI training and inference. IREN’s vertically integrated platform is underpinned by its expansive portfolio of grid-connected land and data centers in renewable-rich regions across the U.S. and Canada.

Contacts

Investors

[email protected]

Media

[email protected]

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or IREN’s future financial or operating performance. Forward-looking statements include information concerning the anticipated inclusion of IREN in the MSCI USA Index, possible or assumed future results of operations, including descriptions of our business plan and strategies, revenue targets and trends we expect to affect our business. These statements often include words such as “anticipate,” “believe,” “may,” “can,” “should,” “could,” “might,” “plan,” “possible,” “project,” “strive,” “budget,” “forecast,” “expect,” “intend,” “target”, “will,” “estimate,” “predict,” “potential,” “continue,” “scheduled”. Forward-looking statements may also be made, verbally or in writing, by members of our Board or management team in connection with this news release.

These forward-looking statements are based on management’s current expectations and beliefs. These statements are neither promises nor guarantees, but involve and are subject to known and unknown risks, uncertainties and other important factors that may cause IREN’s actual results, performance or achievements to differ materially from any future results performance or achievements expressed or implied by the forward-looking statements, including any future decisions by MSCI with respect to the constituents of its indexes or modifications to such constituents, IREN’s ability to successfully execute on its growth strategies and operating plans, achieve its targeted annualized AI Cloud revenue, continue to develop its existing data center sites, design and deploy direct-to-chip liquid cooling systems, and diversify and expand into the market for high performance computing solutions (including the market for cloud services and potential colocation services, along with other important factors discussed under the caption “Risk Factors” in IREN’s Annual Report on Form 10-K, filed with Securities and Exchange Commission (the “SEC”) on August 28, 2025 and our other filings with the SEC. These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any forward-looking statement included in this press release speaks only as of the date of such statement. Except as required by law, IREN disclaims any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise.



U.S. Department of Commerce Increases Duties on Chinese Battery-Grade Graphite to 160%+ in Final Determinations

CHATTANOOGA, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), today acknowledged the U.S. Department of Commerce’s (“Commerce”) final determinations in the antidumping and countervailing duty investigations covering anode active materials (“AAM”) imported into the U.S. from China. The total amount of the tariffs applicable to AAM imported from China will be at least 160%, subject to a final affirmative determination by the U.S. International Trade Commission (“ITC”) that the U.S. AAM industry has been materially impeded because of Chinese AAM imports. The ITC’s final determination is expected in March 2026.

Highlights

Subject to the ITC’s final determination on material impediment:

  • An antidumping duty of 93.5% will be imposed on AAM imports from China from specified companies and a duty of 102.72% will be imposed China-wide on all other exporters
  • A countervailing duty of 66.82% to 66.86% will be imposed on all AAM imports from China producers
  • These duties will remain in effect unless revoked and will be reviewed every five years

“These determinations represent a meaningful step toward restoring fair competition in the U.S. anode materials market,” said Mike O’Kronley, CEO of NOVONIX. “By addressing longstanding trade distortions, these measures strengthen the foundation for domestic production of critical battery materials, accelerate investment in U.S. manufacturing, and support the creation of high-quality advanced manufacturing jobs. We believe this materially enhances NOVONIX’s competitive position as we continue scaling synthetic graphite production in North America.”

The duties apply broadly to anode-graphite materials, as defined by Commerce, including synthetic and natural graphite products, whether coated or uncoated, and blended materials used in lithium-ion battery applications.

The previously imposed 25% tariff under Section 301 of the Trade Act of 1974 and 20% tariff under the International Emergency Economic Powers Act (“IEEPA”) on AAM imports from China remain in effect. The legal validity of the IEEPA tariffs is currently under review by the U.S. Supreme Court.

NOVONIX supports the transparent and rules-based enforcement of U.S. trade laws and believes these determinations represent an important step in promoting fair competition, strengthening domestic battery supply chains, and encouraging long-term capital investment in advanced manufacturing in the United States.

With the most advanced synthetic graphite production capability in North America, NOVONIX is strategically positioned to support customers seeking secure, domestically produced anode materials. The Company continues to execute on its strategy to expand high-performance synthetic graphite production in the United States, reinforcing supply chain resilience, U.S. energy security, and long-term manufacturing competitiveness.

Additional information regarding the determinations is available through the U.S. Department of Commerce’s Enforcement and Compliance records.

This announcement has been authorized for release by NOVONIX Chairman,
Mr. Ron Edmonds.

About NOVONIX

NOVONIX strives to reduce supply chain risk, support U.S. energy independence, and establish a resilient battery materials supply chain. The company is building a North American platform for critical battery materials—anchored by its Chattanooga, Tennessee headquarters and anode materials operations, expanding through its patented all-dry, precursor-free cathode synthesis technology, and supported by industry-leading battery cell testing and R&D services.
Together, these capabilities position NOVONIX as an integrated supplier of advanced battery materials and technologies powering the energy storage and electrification economy.

To learn more, visit us at www.novonixgroup.com or on LinkedIn and X.

For NOVONIX Limited

Investors: [email protected]
Media: [email protected]

Cautionary Note Regarding Forward-Looking Statements

This communication contains forward-looking statements about the Company and the industry in which it operates. Forward-looking statements can generally be identified by use of words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or other similar expressions. Examples of forward-looking statements in this communication include, among others, statements made regarding the creation and development of new technology, anticipated production capacity at its facilities, anticipated customer demand, the impacts of economic uncertainty, tariffs, and other legislation on our timely achievement of targets and customer milestones, our ability to obtain or maintain and benefit from additional government funding and other support, our expectations of the benefit of the antidumping and countervailing duty determinations, tariffs imposed on China and other countries, improving and growing battery testing equipment and research and development services business, continued investment in and efforts to commercialize the cathode synthesis technology, and efforts to help localize the battery supply chain for critical materials and play a leading role in the transition to cleaner energy solutions.

The Company has based such statements on current expectations and projections about future events and trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Such forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the timely deployment and scaling of its furnace technology, ability to meet the technical specifications and demand of existing and future customers, the accuracy of estimates regarding market size, expenses, future revenue, capital requirements, needs and access for additional financing, the availability and impact and compliance with the applicable terms of government funding and other support, ability to obtain patent rights effective to protect its technologies and processes and successfully defend any challenges to such rights and prevent others from commercializing such technologies and processes, and regulatory and economic developments in the United States, Australia, and other jurisdictions. These and other factors that could affect its business and results are included in its filings with the U.S. Securities and Exchange Commission (“SEC”), including the Company’s most recent annual report on Form 20-F. Copies of these filings may be obtained by visiting the Company’s Investor Relations website at www.novonixgroup.com or the SEC’s website at www.sec.gov.

Forward-looking statements are not guarantees of future performance or outcomes, and actual performance and outcomes may differ materially from those made in or suggested by the forward-looking statements contained in this communication. Accordingly, you should not place undue reliance on forward-looking statements. Any forward-looking statement in this communication is based only on information currently available to us and speaks only as of the date on which it is made. The Company undertakes no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.



Granite Declares Quarterly Dividend

Granite Declares Quarterly Dividend

WATSONVILLE, Calif.–(BUSINESS WIRE)–Granite (NYSE:GVA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.13 per common share. The dividend is payable on April 15, 2026, to all shareholders of record at the close of business on March 31, 2026.

About Granite

Granite is America’s Infrastructure Company™. Incorporated since 1922, Granite (NYSE:GVA) is one of the largest diversified construction and construction materials companies in the United States as well as a full-suite civil construction provider. Granite’s Code of Conduct and strong Core Values guide the Company and its employees to uphold the highest ethical standards. Granite is an industry leader in safety and an award-winning firm in quality and sustainability. For more information, visit the Granite website, graniteconstruction.com, and connect with Granite on LinkedIn, X, Facebook, and Instagram.

Granite Contacts

Media

Erin Kuhlman 831-768-4111

Investors

Wenjun Xu – 831-761-7861

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Building Systems Other Construction & Property Residential Building & Real Estate Commercial Building & Real Estate Construction & Property

MEDIA:

Logo
Logo

GE HealthCare announces cash dividend for first quarter of 2026

GE HealthCare announces cash dividend for first quarter of 2026

CHICAGO–(BUSINESS WIRE)–
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

Investor Relations Contact:

Carolynne Borders

+1 631 662 4317

[email protected]

Media Contact:

Jennifer Fox

+ 1 414 530 3027

[email protected]

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Technology Medical Devices Hospitals Health Technology Software Radiology General Health Pharmaceutical Health Artificial Intelligence

MEDIA: